High-dose intravenous magnesium attenuates complement consumption after acute myocardial infarction treated by streptokinase

European Heart Journal

Volumn 17, Issue 5, 1996, Pages 709-714

  Roth, A ^a   Kornowski, R ^a   Agmon, Y ^a   Vardinon, N ^a   Sheps, D ^a   Graph, E ^a   Burke, M ^a   Laniado, S ^a   Yust, I ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Acute myocardial infarction; Complement; Magnesium

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT CH 100; FIBRINOLYTIC FACTOR; MAGNESIUM; MAGNESIUM SULFATE; STREPTOKINASE; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; HUMAN; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 0029897578     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.eurheartj.a014937     Document Type: Article

References (0)